Registry – Page 14 – Macralytics

Non-Muscle Invasive Bladder Cancer: Repeat Transurethral Resection of Bladder Tumor (TURBT) for T1 disease

Percentage of patients with T1 disease who had a second transurethral resection of bladder tumor (TURBT) within 6 weeks of the initial TURBT

Non-Muscle Invasive Bladder Cancer: Initial Management/Surveillance for Non-Muscle Invasive Bladder Cancer

Percentage of patients with appropriate initial management/surveillance after initial diagnosis of non-muscle invasive bladder cancer

Prostate Cancer: Confirmation Biopsy in Newly Diagnosed Patients on Active Surveillance

Percentage of newly diagnosed low risk patients on active surveillance who receive confirmation biopsy within 24 months of diagnosis

Echocardiogram Stewardship in Congestive Heart Failure (CHF): Avoiding Repeat Tests without Clinical Indication

This measure assesses the appropriate use of echocardiograms in patients with CHF. It evaluates the percentage of patients who receive echocardiograms without a clinical change or cardiac procedure within 24 months of the date of service (DOS), indicating potential overuse of this diagnostic test.

SGLT2 Inhibitors for Patients with Chronic Kidney Disease (CKD) with or without type 2 diabetes mellitus

This measure evaluates the percentage of patients aged 18 years and older with chronic kidney disease (CKD) stages 2 and 3 who are prescribed an SGLT2 inhibitor during the measurement period. The goal is to increase the use of SGLT2 inhibitors, which have been shown to slow the progression of CKD and reduce cardiovascular events in this population.

Noninvasive Ischemic Imaging Stewardship in Chronic Coronary Disease: Avoiding Testing without Clinical Indication

This measure assesses the appropriate use of noninvasive ischemic imaging in patients with chronic coronary disease in accordance with the 2023 ACC/AHA guidelines on the management of chronic coronary disease. It evaluates the percentage of patients who received imaging without a clinical change or pre-operative indication, signaling potential overuse of cardiac imaging.

Patient-Reported Experience with Anesthesia

Percentage of patients, aged 18 and older, who were surveyed on their patient experience and satisfaction with anesthesia care and who reported a positive experience.

This measure will consist of two performance rates:

AQI48a: Percentage of patients, aged 18 and older, who were surveyed on their patient experience and satisfaction with anesthesia care

AQI48b: Percentage of patients, aged 18 and older, who completed a survey on their patient experience and satisfaction with anesthesia care who report a positive experience with anesthesia care within 60 days of receipt of the survey.

NOTE: The measure requires that a valid survey, as defined in the numerator of AQI48a, be sent to patients between discharge from the facility and within 30 days of facility discharge. To report AQI48b, a minimum number of 20 surveys with the mandatory question completed must be reported. ** In order to be scored on this measure, clinicians must report BOTH AQI48a AND AQI48b.

Submission Method: Registry